Payment overview · 2025
General Payments
$222.58
4 reported records · 1 companies
Healthcare provider profile · identity verified
Michael J. Fox, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · WILKES BARRE, PA · NPI 1235106238
Verified facts
What the public records show
CMS Open Payments records show Michael J. Fox, M.D. received $222.58 in general payments during 2025 across 4 reported records.
Supreme Orthopedic Systems, LLC accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Supreme Orthopedic Systems, LLC | Unresolved — no canonical attribution shown | $222.58 | 100.0% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $222.58 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 581 | 173 |
| Amlodipine Besylate | Amlodipine Besylate | 443 | 129 |
| Levothyroxine Sodium | Levothyroxine Sodium | 397 | 107 |
| Omeprazole | Omeprazole | 317 | 78 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 309 | 90 |
| Losartan Potassium | Losartan Potassium | 291 | 73 |
| Gabapentin | Gabapentin | 277 | 66 |
| Metoprolol Succinate | Metoprolol Succinate | 249 | 66 |
| Alprazolam | Alprazolam | 240 | 40 |
| Lisinopril | Lisinopril | 217 | 69 |
| Carvedilol | Carvedilol | 177 | 43 |
| Famotidine | Famotidine | 175 | 50 |
| Metformin Hcl | Metformin Hcl | 171 | 45 |
| Potassium Chloride | Potassium Chloride | 149 | 31 |
| Jardiance | Empagliflozin | 143 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 125 | 39 |
| Furosemide | Furosemide | 124 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 123 | 29 |
| Ozempic | Semaglutide | 113 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 110 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 109 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 108 | 29 |
| Warfarin Sodium | Warfarin Sodium | 107 | 26 |
| Sertraline Hcl | Sertraline Hcl | 99 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 99 | 25 |
| Trazodone Hcl | Trazodone Hcl | 93 | 24 |
| Baclofen | Baclofen | 90 | 35 |
| Allopurinol | Allopurinol | 88 | 23 |
| Metformin Hcl Er | Metformin Hcl | 86 | 19 |
| Eliquis | Apixaban | 82 | 27 |
| Lorazepam | Lorazepam | 82 | 18 |
| Pregabalin | Pregabalin | 81 | 17 |
| Glimepiride | Glimepiride | 72 | 12 |
| Simvastatin | Simvastatin | 71 | 18 |
| Chlorthalidone | Chlorthalidone | 67 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 63 | 14 |
| Tramadol Hcl | Tramadol Hcl | 63 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 61 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 60 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 58 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 58 | 20 |
| Torsemide | Torsemide | 57 | 15 |
| Atenolol | Atenolol | 55 | 15 |
| Buspirone Hcl | Buspirone Hcl | 53 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 51 | 22 |
| Ezetimibe | Ezetimibe | 51 | 14 |
| Spironolactone | Spironolactone | 49 | suppressed |
| Novolog Flexpen | Insulin Aspart | 47 | 15 |
| Valsartan | Valsartan | 47 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | suppressed |
| Finasteride | Finasteride | 45 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 45 | 12 |
| Clonazepam | Clonazepam | 40 | suppressed |
| Prednisone | Prednisone | 38 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 35 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 32 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | suppressed |
| Topiramate | Topiramate | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 30 | suppressed |
| Diazepam | Diazepam | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 26 | suppressed |
| Cefdinir | Cefdinir | 23 | 19 |
| Lovastatin | Lovastatin | 23 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 18 |
| Cephalexin | Cephalexin | 21 | 17 |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 12 |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | 11 |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Mirtazapine | Mirtazapine | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Klor-Con M10 | Potassium Chloride | 12 | suppressed |
| Levoxyl | Levothyroxine Sodium | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $222.58 · 4 records | Supreme Orthopedic Systems, LLC | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error